FIELD: chemistry.
SUBSTANCE: present invention relates to compounds of general formula (I),
acting as muscarinic receptors antagonists or beta2-adrenoreceptors agonists, as well as to pharmaceutical compositions based thereon and to therapeutic applications for preparing a medicine to prevent and treat diseases, such as asthma, chronic bronchitis, etc.
EFFECT: obtained are novel compounds of formula (I) having activity towards muscarinic receptors or beta2-adrenoreceptors.
13 cl, 5 tbl, 39 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2013 |
|
RU2661877C2 |
| COMPOUNDS HAVING MUSCARINIC RECEPTOR AGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2016 |
|
RU2709777C2 |
| DERIVATIVES OF PHENYL-3-AMINOMETHYLQUINOLONE-2 AS INHIBITORS OF NO-SYNTHASE, METHOD FOR THEIR PREPARING, BIOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2284325C2 |
| COMPOSITION OF TETRAHYDROQUINOLINES AS BROMODOMAIN BET MODIFYING AGENTS | 2014 |
|
RU2727169C2 |
| IMIDAZOPYRAZINES | 2012 |
|
RU2600327C2 |
| ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
| HETEROCYCLIC HIF ACTIVITY MODULATORS FOR TREATING DISEASES | 2013 |
|
RU2698197C2 |
| METHOD FOR IDENTIFICATION OF ANTI-TUMOR TARGET ENZYMES | 2002 |
|
RU2319482C2 |
| NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
| SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2452735C1 |
